Up 59%, Should You Buy ASML Right Now?

ASML reported Q3 revenue of €7.51 billion (down 2.2% YoY) after selling 66 new and six used lithography systems, with net bookings of €5.4 billion; gross profit was €3.88 billion (51.6% margin) and net income €2.12 billion (EPS €5.49). Management guided Q4 sales of €9.2–9.8 billion with margins of 51–53% and expects full-year net sales roughly 15% above 2024; analysts remain bullish (JPMorgan raised its PT to $1,275) while the company’s exclusive EUV technology underpins a durable competitive moat as the stock trades near all-time highs (market cap ~$428bn, ~59% YTD).

Analysis

Market structure: ASML’s monopoly in EUV gives it outsized pricing power and a de facto duopoly on next‑node logic scaling; immediate beneficiaries are ASML, its mirror/laser suppliers (e.g., Zeiss/Cymer suppliers), and leading foundries (TSM, Samsung, Intel) that can absorb EUV throughput. Q3 bookings (€5.4bn) vs Q4 guidance (€9.2–9.8bn) imply a sharp sequential capex pick‑up into Q4 and FY25 (company guides +~15% y/y), signaling tightening supply of advanced litho capacity vs demand for cutting‑edge nodes.

Risk assessment: Key tail risks are geopolitically driven export controls to China (could cut ASML addressable market by 20–40% over 12–24 months), single‑supplier operational failures (high concentration in mirror/laser supply), and a demand shock if AI/crypto capex cools. Near term (days–weeks) expect volatility on sentiment; medium term (3–12 months) bookings conversion and guidance beats/misses drive earnings; long term (2–5 years) moat intact but dependent on foundry cadence and China access.

Trade implications: Tactical idea is a core long-sized position in ASML with volatility overlays: accumulate 2–4% portfolio long ASML, add on pullbacks of 8–12% from current levels or if price < $1,000, hedge with 3–6 month puts. Consider pair trade long ASML vs short SMH (equal notional) to isolate EUV exposure, and buy Jan 2027 LEAP calls (1.5–2yr) if conviction in structural demand for EUV machines.

Contrarian angles: Consensus is rosy and may underprice cyclic downside — 59% YTD move already prices substantial node ramp through 2026; market may be underestimating single‑customer timing risk (top 4 customers likely >50% revenue). Potential catalysts to reverse rally include tightened export rules or a supplier outage; implied volatility compression could make selling covered call spreads attractive into 2025 guidance dates.

Key Decisions for Investors

• Establish a core long in ASML (2–4% of portfolio) in two tranches: 60% at market, 40% on a pullback of 8–12% or a close below $1,000; set a tactical stop‑loss at 18% below average entry and plan to trim 25% of position at $1,275 (JPM target) within 6–12 months.
• Buy Jan 20, 2027 ASML LEAP calls (strike ~$1,200) sized to 0.5–1% of portfolio to capture multi‑year secular EUV demand; if premiums >8% of notional, instead buy a 24‑month call spread to cap cost.
• Implement a relative value trade: long ASML (notional X) / short SMH (semiconductor ETF) equal notional X to isolate EUV exposure; rebalance quarterly and liquidate if ASML underperforms SMH by >15% within 6 months.
• Hedge geopolitical tail risk: buy six‑month ATM puts on ASML equal to 10–15% of the long position notional (protects against a sudden export‑control shock), or allocate equivalent to cash if export controls are announced within 90 days.